Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Book value per share

Book value per share at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.98-0.6%
ALN
Alnylam PharmaceuticalsALNY
$7.78+137%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$18.89-11.2%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$11.28-12.2%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.72-27.5%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$7.43-22.1%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.13B+106%
Enterprise value$2.08B+100%
P/S32.2×+9.5×

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Calculated from Intellia Therapeutics’s reported figures.

total stockholders equity/weighted shares diluted=$5.24

Based on the most recent quarter.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's book value per share?
Intellia Therapeutics (NTLA) reported book value per share of $5.24 in Q1 2026.
How has Intellia Therapeutics's book value per share changed year-over-year?
Intellia Therapeutics's book value per share decreased by 30.5% year-over-year, from $7.54 to $5.24.
What is the long-term trend for Intellia Therapeutics's book value per share?
Over 5 years (2020 to 2025), Intellia Therapeutics's book value per share has grown at a -6.3% compound annual growth rate (CAGR), from $8.60 to $6.20.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.